
Pharmaxi Poland sp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Pharmaxi Poland is a mid-sized CRO operating in Ukraine, Poland and other European countries. It conducts phase III–IV clinical trials, postmarketing studies and registries, and provides clinical evaluation of medical devices and IVDs, alongside clinical operations, medical writing, data management and other services. The company uses its proprietary OnlineCRF EDC system and works with local vendors.
Financials
Revenue history (in k)
From the notes
| Profit allocation | Loss covered |
Filing timeliness
3 of 4 financial statements were filed late (the longest delay 660 days for 2022).
- 202503/07/2026
- 202428/01/2026
- 202305/05/2025
- 202205/05/2025
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Clinical trials
- Post-marketing studies
- Trial management
- Medical writing
- Biostatistical analysis
- Regulatory support
- Clinical data management
- EDC system
Website technology
- Analytics and marketing
- Google Tag Manager
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Tetiana Lebid age 45 | 19 | $256.62 | 19% |
Yurii Lebid age 45 | 81 | $1,094.00 | 81% |
Yurii Lebid and Tetiana Lebid hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2022-04-18.
03 1020 4274 0000 1102 0092 6980
72 1020 4274 0000 1302 0092 6998
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| 2kmm sp. z o.o. | $1,358,321.52 | 2kmm.pl | ||
| Scientia Cro sp. z o.o. | $607,622.19 | scientiacro.com | ||
| CTI Clinical Trial and Consulting Services Poland sp. z o.o. | $527,145.56 | ctifacts.com | ||
| MDR Regulator sp. z o.o. | $377,079.69 | pureclinical.eu | ||
| Genelytica sp. z o.o. | $213,207.91 | genelytica.pl | ||
| Monipol Biotech Pl sp. z o.o. | $191,735.74 | monipol-biotech.com | ||
| GCP-Service International Ltd. & Co. Kg Branch (foreign co.) | $159,376.34 | gcp-service.com | ||
| Quantum Satis sp. z o.o. | $82,346.73 | quantumsatis.pl | ||
| Medapp Clinical Research sp. z o.o. | $55,499.75 | medappclinicalresearch.pl | ||
| Biostat Research and Development sp. z o.o. | $50,225.77 | biostat.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-02-05 | Address change (Ul. Tomasza Zana 43/2.1, 20-601, Lublin → Ul. Korytnicka 46/52, 04-109, Warszawa) | |
| 2022-03-24 | Entered in the register |
FAQ
Last updated: 2026-07-06